Healthcare provider profile · identity verified

Katherine Elizabeth Ayers, MD

Internal Medicine · BRUNSWICK, OH · NPI 1962687871

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	466	126
Levothyroxine Sodium	Levothyroxine Sodium	426	102
Lisinopril	Lisinopril	411	110
Atorvastatin Calcium	Atorvastatin Calcium	410	117
Hydrochlorothiazide	Hydrochlorothiazide	325	85
Rosuvastatin Calcium	Rosuvastatin Calcium	308	84
Simvastatin	Simvastatin	218	53
Losartan Potassium	Losartan Potassium	213	56
Metformin Hcl	Metformin Hcl	207	62
Omeprazole	Omeprazole	200	58
Sertraline Hcl	Sertraline Hcl	174	51
Metoprolol Succinate	Metoprolol Succinate	156	43
Furosemide	Furosemide	143	42
Potassium Chloride	Potassium Chloride	139	37
Metoprolol Tartrate	Metoprolol Tartrate	131	33
Pantoprazole Sodium	Pantoprazole Sodium	124	31
Albuterol Sulfate Hfa	Albuterol Sulfate	120	35
Pravastatin Sodium	Pravastatin Sodium	110	31
Atenolol	Atenolol	108	30
Carvedilol	Carvedilol	104	29
Glipizide Er	Glipizide	82	21
Trazodone Hcl	Trazodone Hcl	81	24
Duloxetine Hcl	Duloxetine Hcl	79	21
Gabapentin	Gabapentin	75	25
Allopurinol	Allopurinol	68	21
Nebivolol Hcl	Nebivolol Hcl	66	20
Ozempic	Semaglutide	63	15
Escitalopram Oxalate	Escitalopram Oxalate	62	19
Bupropion Xl	Bupropion Hcl	58	12
Ezetimibe	Ezetimibe	55	15
Spironolactone	Spironolactone	55	13
Fluoxetine Hcl	Fluoxetine Hcl	51	12
Prednisone	Prednisone	50	39
Tamsulosin Hcl	Tamsulosin Hcl	49	16
Oxybutynin Chloride Er	Oxybutynin Chloride	46	13
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Alprazolam	Alprazolam	44	11
Metformin Hcl Er	Metformin Hcl	44	11
Hydroxyzine Hcl	Hydroxyzine Hcl	42	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	16
Buspirone Hcl	Buspirone Hcl	40	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	13
Meclizine Hcl	Meclizine Hcl	40	13
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Eliquis	Apixaban	39	11
Synthroid	Levothyroxine Sodium	38	suppressed
Mounjaro	Tirzepatide	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Lovastatin	Lovastatin	36	suppressed
Meloxicam	Meloxicam	36	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	33	11
Celecoxib	Celecoxib	32	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Azithromycin	Azithromycin	30	29
Fluticasone Propionate	Fluticasone Propionate	30	15
Glipizide	Glipizide	29	suppressed
Xarelto	Rivaroxaban	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	20
Januvia	Sitagliptin Phosphate	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Fluconazole	Fluconazole	22	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Famotidine	Famotidine	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	17
Etodolac	Etodolac	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	18	suppressed
Amoxicillin	Amoxicillin	17	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Fenofibrate	Fenofibrate	17	suppressed
Indapamide	Indapamide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Ramipril	Ramipril	16	suppressed
Torsemide	Torsemide	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Glyburide	Glyburide	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Linzess	Linaclotide	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Tradjenta	Linagliptin	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Nystatin	Nystatin	13	suppressed
Primidone	Primidone	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error